The PKM2 inhibitor shikonin enhances piceatannol‐induced apoptosis of glyoxalase I‐dependent cancer cells
Genes to Cells · 2024
DOI: 10.1111/gtc.13084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2024. Verfasst von Manami Inoue und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan. Hauptthemen laut MEDLINE: Lactoylglutathione Lyase, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Glyoxalase I (GLO I), a major enzyme involved in the detoxification of the anaerobic glycolytic byproduct methylglyoxal, is highly expressed in various tumors, and is regarded as a promising target for cancer therapy. We recently reported that piceatannol potently inhibits human GLO I and induces the death of GLO I‐dependent cancer cells. Pyruvate kinase M2 (PKM2) is also a potential therapeutic target for cancer treatment, so we evaluated the combined anticancer efficacy of piceatannol plus low‐dose shikonin, a potent and specific plant‐derived PKM2 inhibitor, in two GLO I‐dependent cancer cell lines, HL‐60 human myeloid leukemia cells and NCI‐H522 human non‐small‐cell lung cancer cells. Combined treatment with piceatannol and low‐dose shikonin for 48 h synergistically reduced cell viability, enhanced apoptosis rate, and increased extracellular methylglyoxal accumulation compared to single‐agent treatment, but did not alter PKM1, PKM2, or GLO I protein expression. Taken together, these results indicate that concomitant use of low‐dose shikonin potentiates piceatannol‐induced apoptosis of GLO I‐dependent cancer cells by augmenting methylglyoxal accumulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
ORCID-Profile: Ryoko Takasawa
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Inoue, M., Nakagawa, Y., Azuma, M., Akahane, H., Chimori, R., Mano, Y., & Takasawa, R. (2024). The PKM2 inhibitor shikonin enhances piceatannol‐induced apoptosis of glyoxalase I‐dependent cancer cells. Genes to Cells. https://doi.org/10.1111/gtc.13084
Vancouver
Inoue M, Nakagawa Y, Azuma M, Akahane H, Chimori R, Mano Y, et al. The PKM2 inhibitor shikonin enhances piceatannol‐induced apoptosis of glyoxalase I‐dependent cancer cells. Genes to Cells. 2024. doi:10.1111/gtc.13084
BibTeX
@article{Inoue2024,
author = {Inoue, Manami and Nakagawa, Yuki and Azuma, Miku and Akahane, Haruka and Chimori, Ryusei and Mano, Yasunari and Takasawa, Ryoko},
title = {The PKM2 inhibitor shikonin enhances piceatannol‐induced apoptosis of glyoxalase I‐dependent cancer cells},
journal = {Genes to Cells},
year = {2024},
doi = {10.1111/gtc.13084}
}
EUVIMED